<p>随着欧洲的 STOXX 600 指数在对未来收益和经济复苏的乐观情绪中徘徊于历史高位，投资者越来越关注那些拥有大量内部持股的成长型公司。这些公司通常反映出与业务最亲近的人士的强烈信心，使其在谨慎乐观的市场环境中显得尤为吸引人。</p>
<h3>欧洲内部持股比例高的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>Warimpex Finanz- und Beteiligungs (WBAG:WXF)</td>
<td>25.9%</td>
<td>100.6%</td>
</tr>
<tr>
<td>S.M.A.I.O (ENXTPA:ALSMA)</td>
<td>16.1%</td>
<td>72.8%</td>
</tr>
<tr>
<td>MilDef Group (OM:MILDEF)</td>
<td>13.7%</td>
<td>83%</td>
</tr>
<tr>
<td>Magnora (OB:MGN)</td>
<td>10.4%</td>
<td>75.1%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>61.2%</td>
</tr>
<tr>
<td>Guard Therapeutics International (OM:GUARD)</td>
<td>13.1%</td>
<td>103.3%</td>
</tr>
<tr>
<td>DNO (OB:DNO)</td>
<td>13.5%</td>
<td>97.5%</td>
</tr>
<tr>
<td>CTT Systems (OM:CTT)</td>
<td>17.5%</td>
<td>52%</td>
</tr>
<tr>
<td>Circus (XTRA:CA1)</td>
<td>24.1%</td>
<td>66.1%</td>
</tr>
<tr>
<td>Bonesupport Holding (OM:BONEX)</td>
<td>10.4%</td>
<td>49.7%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们关于内部持股比例高的快速成长欧洲公司的 208 只股票的完整列表。</p>
<p>让我们更仔细地看看我们从筛选公司中挑选的几家公司。</p>
<h2>CTT Systems (OM:CTT)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> CTT Systems AB (publ) 在瑞典、丹麦、法国、美国及其他国际市场开发和提供飞机湿度控制系统，市值为 25 亿瑞典克朗。</p>
<p><strong>运营：</strong> CTT Systems AB 的收入来自其航空航天与国防部门，金额为 2.912 亿瑞典克朗。</p>
<p><strong>内部持股：</strong> 17.5%</p>
<p><strong>股本回报率预测：</strong> 45%（2028 年估计）</p>
<p>CTT Systems 展现出强劲的增长潜力，预计收益将以每年 52% 的速度显著增长，超过瑞典市场。收入预计每年增长 25.2%，同样高于市场水平。尽管交易价格大幅低于估计的公允价值，但最近的业绩显示出混合表现，利润率下降，九个月的净收入较去年有所减少。2.69% 的股息收益率缺乏收益或自由现金流的支持。</p>
<ul>
<li>解锁我们对 CTT Systems 股票分析的全面见解，尽在本成长报告中。</li>
<li>我们的 CTT Systems 估值报告中的分析暗示其股价相较于估计值被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b9f83b6-98fc-4082-8f80-2e0fce91d9b4/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b9f83b6-98fc-4082-8f80-2e0fce91d9b4/chart/ownership-breakdown"/></p>
<p>截至 2026 年 1 月的 OM:CTT 持股分布</p>
<h2>Lime Technologies (OM:LIME)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Lime Technologies AB (publ) 主要在北欧地区提供基于 SaaS 的 CRM 解决方案，市值约为 38.2 亿瑞典克朗。</p>
<p><strong>运营：</strong> 公司的收入主要来自销售和实施 CRM 软件系统，金额约为 7.3163 亿瑞典克朗。</p>
<p><strong>内部持股：</strong> 10.4%</p>
<p><strong>股本回报率预测：</strong> 32%（2028 年估计）</p>
<p>Lime Technologies 展现出强劲的增长前景，预计收益将以每年 20.8% 的速度显著增长，超过瑞典市场水平。收入预计以每年 10.8% 的速度增长，但仍高于市场平均水平。该公司交易价格显著低于其估计的公允价值，最近的高管变动表明未来扩展阶段的战略一致性。第三季度的业绩报告显示销售和净收入增加，反映出持续的运营实力。</p>
<ul>
<li>点击这里了解 Lime Technologies 的细微差别，获取我们的详细分析未来增长报告。</li>
<li>我们最近的估值报告指出 Lime Technologies 的股票在市场上可能被低估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3ca4bc24-fcf9-458b-9c13-3dbebb04ed91/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3ca4bc24-fcf9-458b-9c13-3dbebb04ed91/chart/ownership-breakdown"/></p>
<p>截至 2026 年 1 月的 OM:LIME 持股分布</p>
<h2>Medicover (OM:MCOV B)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Medicover AB (publ) 在波兰、瑞典及国际上运营医疗和诊断服务，市值为 332.9 亿瑞典克朗。</p>
<p><strong>运营：</strong> 该公司从两个主要部门产生收入：医疗服务收入为 16.2 亿欧元，诊断服务收入为 7.321 亿欧元。</p>
<p><strong>内部持股：</strong> 11.2%</p>
<p><strong>股本回报率预测：</strong> 24%（2028 年估计）</p>
<p>Medicover 展现出良好的增长前景，预计收益将以每年 25.1% 的速度显著增长，超过瑞典市场。收入预计以每年 10.8% 的速度增长，快于市场平均水平。最近的内部购买相当可观，表明对未来前景的信心。该公司交易价格低于其公允价值估计，第三季度的业绩显示销售增加并恢复盈利，突显出运营改善和在 MRD 检测开发中的战略进展。</p>
<ul>
<li>在我们的收益增长报告中更仔细地看看 Medicover 的潜力。</li>
<li>我们的全面估值报告提出 Medicover 的价格可能低于其财务状况所能证明的水平。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12b417bf-5706-4899-9ca5-59fa1e6ea4cc/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12b417bf-5706-4899-9ca5-59fa1e6ea4cc/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 1 月的 OM:MCOV B 收益和收入增长</p>
<h2>利用机会</h2>
<ul>
<li>点击这里揭示我们快速成长的欧洲公司中 208 个隐藏的宝石。</li>
<li>准备进入其他投资风格吗？特朗普承诺要 “释放” 美国的石油和天然气，这 22 只美国股票的发展有望受益。</li>
</ul>
<p>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有引用的预测收入和盈利增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</p>
<p>国防与灾难的移动基础设施</p>
<p>下一波机器人技术不是类人型的，而是完全自主的塔楼，能够在 30 分钟内提供 5G、ISR 和雷达服务，覆盖任何地点。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>由 CiTech 赞助</p>

<p>随着欧洲的 STOXX 600 指数接近历史高点，投资者正关注那些内部持股比例高的成长型公司，这表明了强烈的信心。值得注意的公司包括 Warimpex Finanz- und Beteiligungs（内部持股 25.9%，盈利增长 100.6%）、S.M.A.（16.1%，72.8%）和 CTT Systems（17.5%，52%）。尽管近期表现不一，CTT Systems 仍显示出潜力，预计年盈利增长 52%。Lime Technologies（10.4% 持股，20.8% 增长）和 Medicover（11.2%，25.1%）也展现出强劲的增长前景，交易价格低于公允价值。分析强调了在谨慎乐观的市场中，这些公司的吸引力</p>

<p>As Europe’s STOXX 600 Index hovers near record highs amid optimism about future earnings and economic recovery, investors are increasingly focusing on growth companies with substantial insider ownership. Such companies often reflect strong confidence from those closest to the business, making them attractive in a market environment where cautious optimism prevails.</p>
<div class="lb-trans"><p>随着欧洲的 STOXX 600 指数在对未来收益和经济复苏的乐观情绪中徘徊于历史高位，投资者越来越关注那些拥有大量内部持股的成长型公司。这些公司通常反映出与业务最亲近的人士的强烈信心，使其在谨慎乐观的市场环境中显得尤为吸引人。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In Europe</h3>
<div class="lb-trans"><h3>欧洲内部持股比例高的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Warimpex Finanz- und Beteiligungs (WBAG:WXF)</td>
<td>25.9%</td>
<td>100.6%</td>
</tr>
<tr>
<td>S.M.A.I.O (ENXTPA:ALSMA)</td>
<td>16.1%</td>
<td>72.8%</td>
</tr>
<tr>
<td>MilDef Group (OM:MILDEF)</td>
<td>13.7%</td>
<td>83%</td>
</tr>
<tr>
<td>Magnora (OB:MGN)</td>
<td>10.4%</td>
<td>75.1%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>61.2%</td>
</tr>
<tr>
<td>Guard Therapeutics International (OM:GUARD)</td>
<td>13.1%</td>
<td>103.3%</td>
</tr>
<tr>
<td>DNO (OB:DNO)</td>
<td>13.5%</td>
<td>97.5%</td>
</tr>
<tr>
<td>CTT Systems (OM:CTT)</td>
<td>17.5%</td>
<td>52%</td>
</tr>
<tr>
<td>Circus (XTRA:CA1)</td>
<td>24.1%</td>
<td>66.1%</td>
</tr>
<tr>
<td>Bonesupport Holding (OM:BONEX)</td>
<td>10.4%</td>
<td>49.7%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>Warimpex Finanz- und Beteiligungs (WBAG:WXF)</td>
<td>25.9%</td>
<td>100.6%</td>
</tr>
<tr>
<td>S.M.A.I.O (ENXTPA:ALSMA)</td>
<td>16.1%</td>
<td>72.8%</td>
</tr>
<tr>
<td>MilDef Group (OM:MILDEF)</td>
<td>13.7%</td>
<td>83%</td>
</tr>
<tr>
<td>Magnora (OB:MGN)</td>
<td>10.4%</td>
<td>75.1%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>61.2%</td>
</tr>
<tr>
<td>Guard Therapeutics International (OM:GUARD)</td>
<td>13.1%</td>
<td>103.3%</td>
</tr>
<tr>
<td>DNO (OB:DNO)</td>
<td>13.5%</td>
<td>97.5%</td>
</tr>
<tr>
<td>CTT Systems (OM:CTT)</td>
<td>17.5%</td>
<td>52%</td>
</tr>
<tr>
<td>Circus (XTRA:CA1)</td>
<td>24.1%</td>
<td>66.1%</td>
</tr>
<tr>
<td>Bonesupport Holding (OM:BONEX)</td>
<td>10.4%</td>
<td>49.7%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 208 stocks from our Fast Growing European Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们关于内部持股比例高的快速成长欧洲公司的 208 只股票的完整列表。</p>
</div><p>Let's take a closer look at a couple of our picks from the screened companies.</p>
<div class="lb-trans"><p>让我们更仔细地看看我们从筛选公司中挑选的几家公司。</p>
</div><h2>CTT Systems (OM:CTT)</h2>
<div class="lb-trans"><h2>CTT Systems (OM:CTT)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> CTT Systems AB (publ) develops and supplies humidity control systems for aircraft across Sweden, Denmark, France, the United States, and other international markets, with a market cap of SEK2.50 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> CTT Systems AB (publ) 在瑞典、丹麦、法国、美国及其他国际市场开发和提供飞机湿度控制系统，市值为 25 亿瑞典克朗。</p>
</div><p><strong>Operations:</strong> CTT Systems AB generates revenue from its Aerospace &amp; Defense segment, amounting to SEK291.20 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> CTT Systems AB 的收入来自其航空航天与国防部门，金额为 2.912 亿瑞典克朗。</p>
</div><p><strong>Insider Ownership:</strong> 17.5%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 17.5%</p>
</div><p><strong>Return On Equity Forecast:</strong> 45% (2028 estimate)</p>
<div class="lb-trans"><p><strong>股本回报率预测：</strong> 45%（2028 年估计）</p>
</div><p>CTT Systems exhibits strong growth potential with earnings forecasted to grow significantly at 52% annually, outpacing the Swedish market. Revenue is expected to rise by 25.2% per year, also above market rates. Despite trading at a substantial discount to estimated fair value, recent results show mixed performance with declining profit margins and lower nine-month net income compared to last year. The dividend yield of 2.69% lacks coverage from earnings or free cash flow.</p>
<div class="lb-trans"><p>CTT Systems 展现出强劲的增长潜力，预计收益将以每年 52% 的速度显著增长，超过瑞典市场。收入预计每年增长 25.2%，同样高于市场水平。尽管交易价格大幅低于估计的公允价值，但最近的业绩显示出混合表现，利润率下降，九个月的净收入较去年有所减少。2.69% 的股息收益率缺乏收益或自由现金流的支持。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of CTT Systems stock in this growth report.</li>
<li>The analysis detailed in our CTT Systems valuation report hints at an inflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对 CTT Systems 股票分析的全面见解，尽在本成长报告中。</li>
<li>我们的 CTT Systems 估值报告中的分析暗示其股价相较于估计值被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b9f83b6-98fc-4082-8f80-2e0fce91d9b4/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/0b9f83b6-98fc-4082-8f80-2e0fce91d9b4/chart/ownership-breakdown"/></p>
<p>OM:CTT Ownership Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 OM:CTT 持股分布</p>
</div><h2>Lime Technologies (OM:LIME)</h2>
<div class="lb-trans"><h2>Lime Technologies (OM:LIME)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Lime Technologies AB (publ) offers SaaS-based CRM solutions primarily in the Nordic region and has a market capitalization of approximately SEK3.82 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Lime Technologies AB (publ) 主要在北欧地区提供基于 SaaS 的 CRM 解决方案，市值约为 38.2 亿瑞典克朗。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from selling and implementing CRM software systems, amounting to approximately SEK731.63 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自销售和实施 CRM 软件系统，金额约为 7.3163 亿瑞典克朗。</p>
</div><p><strong>Insider Ownership:</strong> 10.4%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 10.4%</p>
</div><p><strong>Return On Equity Forecast:</strong> 32% (2028 estimate)</p>
<div class="lb-trans"><p><strong>股本回报率预测：</strong> 32%（2028 年估计）</p>
</div><p>Lime Technologies demonstrates robust growth prospects with earnings expected to grow significantly at 20.8% annually, surpassing the Swedish market rate. Revenue is forecasted to increase at a slower pace of 10.8% per year but still above market averages. The company trades at a notable discount to its estimated fair value, and recent executive changes suggest strategic alignment for future expansion phases. Third-quarter results reported increased sales and net income, reflecting ongoing operational strength.</p>
<div class="lb-trans"><p>Lime Technologies 展现出强劲的增长前景，预计收益将以每年 20.8% 的速度显著增长，超过瑞典市场水平。收入预计以每年 10.8% 的速度增长，但仍高于市场平均水平。该公司交易价格显著低于其估计的公允价值，最近的高管变动表明未来扩展阶段的战略一致性。第三季度的业绩报告显示销售和净收入增加，反映出持续的运营实力。</p>
</div><ul>
<li>Click here to discover the nuances of Lime Technologies with our detailed analytical future growth report.</li>
<li>Insights from our recent valuation report point to the potential undervaluation of Lime Technologies shares in the market.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里了解 Lime Technologies 的细微差别，获取我们的详细分析未来增长报告。</li>
<li>我们最近的估值报告指出 Lime Technologies 的股票在市场上可能被低估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3ca4bc24-fcf9-458b-9c13-3dbebb04ed91/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/3ca4bc24-fcf9-458b-9c13-3dbebb04ed91/chart/ownership-breakdown"/></p>
<p>OM:LIME Ownership Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 OM:LIME 持股分布</p>
</div><h2>Medicover (OM:MCOV B)</h2>
<div class="lb-trans"><h2>Medicover (OM:MCOV B)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Medicover AB (publ) operates healthcare and diagnostic services in Poland, Sweden, and internationally with a market cap of SEK33.29 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Medicover AB (publ) 在波兰、瑞典及国际上运营医疗和诊断服务，市值为 332.9 亿瑞典克朗。</p>
</div><p><strong>Operations:</strong> The company generates revenue from two main segments: €1.62 billion from Healthcare Services and €732.10 million from Diagnostic Services.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司从两个主要部门产生收入：医疗服务收入为 16.2 亿欧元，诊断服务收入为 7.321 亿欧元。</p>
</div><p><strong>Insider Ownership:</strong> 11.2%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 11.2%</p>
</div><p><strong>Return On Equity Forecast:</strong> 24% (2028 estimate)</p>
<div class="lb-trans"><p><strong>股本回报率预测：</strong> 24%（2028 年估计）</p>
</div><p>Medicover shows promising growth with earnings expected to rise significantly at 25.1% annually, outpacing the Swedish market. Revenue is forecasted to grow at 10.8% per year, faster than the market average. Insider buying has been substantial recently, indicating confidence in future prospects. The company trades below its fair value estimate and third-quarter results revealed increased sales and a return to profitability, highlighting operational improvements and strategic advancements in their MRD assay development.</p>
<div class="lb-trans"><p>Medicover 展现出良好的增长前景，预计收益将以每年 25.1% 的速度显著增长，超过瑞典市场。收入预计以每年 10.8% 的速度增长，快于市场平均水平。最近的内部购买相当可观，表明对未来前景的信心。该公司交易价格低于其公允价值估计，第三季度的业绩显示销售增加并恢复盈利，突显出运营改善和在 MRD 检测开发中的战略进展。</p>
</div><ul>
<li>Take a closer look at Medicover's potential here in our earnings growth report.</li>
<li>Our comprehensive valuation report raises the possibility that Medicover is priced lower than what may be justified by its financials.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的收益增长报告中更仔细地看看 Medicover 的潜力。</li>
<li>我们的全面估值报告提出 Medicover 的价格可能低于其财务状况所能证明的水平。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12b417bf-5706-4899-9ca5-59fa1e6ea4cc/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/12b417bf-5706-4899-9ca5-59fa1e6ea4cc/chart/earnings-and-revenue-growth"/></p>
<p>OM:MCOV B Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 OM:MCOV B 收益和收入增长</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用机会</h2>
</div><ul>
<li>Reveal the 208 hidden gems among our Fast Growing European Companies With High Insider Ownership screener with a single click here.</li>
<li>Ready To Venture Into Other Investment Styles? Trump has pledged to &#34;unleash&#34; American oil and gas and these 22 US stocks have developments that are poised to benefit.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里揭示我们快速成长的欧洲公司中 208 个隐藏的宝石。</li>
<li>准备进入其他投资风格吗？特朗普承诺要 “释放” 美国的石油和天然气，这 22 只美国股票的发展有望受益。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有引用的预测收入和盈利增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>国防与灾难的移动基础设施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人型的，而是完全自主的塔楼，能够在 30 分钟内提供 5G、ISR 和雷达服务，覆盖任何地点。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 赞助</p>
</div>

2026 年 1 月欧洲内部持股比例高的成长型公司